News

Article

Ed Buffington, president and CEO of GPN Technologies, to receive 2024 Person of Vision Award from Prevent Blindness

The Person of Vision Award gala will be held on March 14, 2024.

(Image Credit: AdobeStock)

(Image Credit: AdobeStock)

Prevent Blindness has announced the recipient of the 2024 Person of Vision Award as Ed Buffington, president and CEO of GPN Technologies.

“The Prevent Blindness Person of Vision Award recognizes an individual, corporation and/or organization whose inspired outlook champions healthy vision and its importance for a healthy life,” according to the organization.1

In a press release, Prevent Blindness stated Buffington was chosen as the recipient of the 2024 Person of Vision Award for “years of outstanding service in the optical and eyecare industry.”

Buffington began his career in the optical industry in 1979 as part of the contact lens company, American Hydron. In 1983, with his partners, he launched OfficeMate Software installing the first eyecare practice management software system to run on an IBM PC in April 1984.1

In 1994, Marchon acquired OfficeMate, which was later acquired by VSP. After retiring from VSP in 2014, Buffington began his private consulting firm, The Buffington Company.1

“I am humbled and honored to receive this very special industry recognition from Prevent Blindness, thank you!” said Buffington in a press release. “I want to thank all the wonderful friends and partners I’ve worked with throughout my tenure in eyecare. It’s those relationships that have contributed to my success and enjoyment in my career.”

Prevent Blindness will also celebrate the 50th Anniversary of 20/20 Magazine at the Person of Vision Award gala.

“We are incredibly honored that Prevent Blindness will be recognizing the 50th Anniversary of 20/20 Magazine at the Person of Vision Dinner in March,” said James DeMatteis, Group Publisher, 20/20 and Vision Monday. “Achieving this milestone is something Jobson is both humbled by and very proud of—not only of the accomplishments this anniversary represents, but also of the tremendous strides the optical arena has achieved these past five decades.”

References:
  1. Annual Prevent Blindness Person of Vision Award Gala at Vision Expo East to Honor Ed Buffington, GPN Technologies, and Recognize 20/20 Magazine for 50 Years of Publication. Press Release. Released September 28, 2023. Accessed September 29, 2023. https://preventblindness.org/2024-person-of-vision-honoree-announced/

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.